Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZFP395 mRNA] | CTD | PMID:31150632 | (-)-demecolcine | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Demecolcine results in decreased expression of ZNF395 mRNA | CTD | PMID:23649840 | (1->4)-beta-D-glucan | multiple interactions | ISO | Zfp395 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP395 mRNA | CTD | PMID:36331819 | 1,2-dichloroethane | increases expression | ISO | Zfp395 (Mus musculus) | 6480464 | ethylene dichloride results in increased expression of ZFP395 mRNA | CTD | PMID:28960355 | 17beta-estradiol | affects expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Estradiol affects the expression of ZNF395 mRNA | CTD | PMID:22574217 | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of ZFP395 mRNA | CTD | PMID:32145629 | 17beta-estradiol | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of ZNF395 mRNA | CTD | PMID:30165855 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ZFP395 mRNA | CTD | PMID:18691609 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Zfp395 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of ZFP395 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZFP395 mRNA | CTD | PMID:21889950 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ZNF395 mRNA | CTD | PMID:20106945 | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | 3 more ... | CTD | PMID:19692669 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of ZFP395 mRNA | CTD | PMID:25172293 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF395 mRNA | CTD | PMID:28628672 | 4,4'-sulfonyldiphenol | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | bisphenol S results in decreased expression of ZNF395 mRNA | CTD | PMID:27685785 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of ZFP395 mRNA | CTD | PMID:28959563 | acrylamide | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of ZNF395 mRNA | CTD | PMID:32763439 | aflatoxin B1 | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased expression of ZNF395 mRNA | CTD | PMID:21641981 and PMID:27153756 | amphetamine | decreases expression | EXP | | 6480464 | Amphetamine results in decreased expression of ZFP395 mRNA | CTD | PMID:30779732 | antirheumatic drug | increases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of ZNF395 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of ZNF395 mRNA | CTD | PMID:33212167 | atrazine | increases expression | EXP | | 6480464 | Atrazine results in increased expression of ZFP395 mRNA | CTD | PMID:36841081 | benzo[a]pyrene | increases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of ZNF395 mRNA | CTD | PMID:20106945 | benzo[a]pyrene | decreases methylation | ISO | ZNF395 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ZNF395 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of ZNF395 mRNA | CTD | PMID:21632981 and PMID:26238291 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bis(2-ethylhexyl) phthalate | increases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of ZFP395 mRNA | CTD | PMID:28085963 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ZFP395 mRNA and bisphenol A affects the expression of ZNF395 mRNA | CTD | PMID:25181051 and PMID:32145629 | bisphenol A | affects expression | ISO | ZNF395 (Homo sapiens) | 6480464 | bisphenol A affects the expression of ZNF395 mRNA | CTD | PMID:30903817 | bisphenol A | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF395 mRNA | CTD | PMID:28628672 | buta-1,3-diene | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | 1 and 3-butadiene results in decreased expression of ZFP395 mRNA | CTD | PMID:29038090 | butanal | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of ZNF395 mRNA | CTD | PMID:26079696 | captan | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Captan results in decreased expression of ZFP395 mRNA | CTD | PMID:31558096 | carbamazepine | affects expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of ZNF395 mRNA | CTD | PMID:25979313 | carbon nanotube | increases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in increased expression of ZFP395 mRNA | CTD | PMID:25620056 | carbon nanotube | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:25620056 | CGP 52608 | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ZNF395 gene] | CTD | PMID:28238834 | chlorpyrifos | increases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of ZFP395 mRNA | CTD | PMID:37019170 | copper(II) sulfate | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of ZNF395 mRNA | CTD | PMID:19549813 | coumestrol | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of ZNF395 mRNA | CTD | PMID:19167446 | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of ZFP395 mRNA | CTD | PMID:26577399 | cyclosporin A | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ZNF395 mRNA | CTD | PMID:20106945 and PMID:25562108 | dexamethasone | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF395 mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of ZFP395 mRNA | CTD | PMID:21266533 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of ZFP395 mRNA | CTD | PMID:21266533 | dichloroacetic acid | increases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Dichloroacetic Acid results in increased expression of ZFP395 mRNA | CTD | PMID:28962523 | dorsomorphin | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF395 mRNA | CTD | PMID:27188386 | ethanol | affects splicing | ISO | Zfp395 (Mus musculus) | 6480464 | Ethanol affects the splicing of ZFP395 mRNA | CTD | PMID:30319688 | folic acid | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of ZFP395 mRNA | CTD | PMID:25629700 | folpet | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | folpet results in decreased expression of ZFP395 mRNA | CTD | PMID:31558096 | formaldehyde | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of ZNF395 mRNA | CTD | PMID:23649840 | fulvestrant | increases methylation | ISO | ZNF395 (Homo sapiens) | 6480464 | Fulvestrant results in increased methylation of ZNF395 gene | CTD | PMID:31601247 | furan | increases methylation | EXP | | 6480464 | furan results in increased methylation of ZFP395 gene | CTD | PMID:22079235 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of ZFP395 mRNA | CTD | PMID:33387578 | hydrogen peroxide | affects expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of ZNF395 mRNA | CTD | PMID:20044591 | indole-3-methanol | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZFP395 mRNA | CTD | PMID:22129741 | indometacin | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of ZNF395 mRNA | CTD | PMID:28628672 | iron dichloride | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | ferrous chloride results in decreased expression of ZNF395 mRNA | CTD | PMID:35984750 | lipopolysaccharide | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Lipopolysaccharides results in decreased expression of ZFP395 mRNA | CTD | PMID:25890327 | lipopolysaccharide | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of ZNF395 mRNA | CTD | PMID:35811015 | lipopolysaccharide | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | menadione | affects expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of ZNF395 mRNA | CTD | PMID:20044591 | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of ZFP395 mRNA | CTD | PMID:30467583 | methoxychlor | affects methylation | EXP | | 6480464 | Methoxychlor affects the methylation of ZFP395 gene | CTD | PMID:35440735 | methylmercury chloride | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of ZNF395 mRNA | CTD | PMID:28001369 | miconazole | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Miconazole results in decreased expression of ZFP395 mRNA | CTD | PMID:27462272 | N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZFP395 mRNA | CTD | PMID:22129741 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of ZFP395 mRNA | CTD | PMID:22129741 | paracetamol | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of ZNF395 mRNA | CTD | PMID:29067470 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of ZFP395 mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Zfp395 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of ZFP395 mRNA | CTD | PMID:36331819 | phenylmercury acetate | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in decreased expression of ZNF395 mRNA | CTD | PMID:26272509 | phenylmercury acetate | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF395 mRNA | CTD | PMID:27188386 | pregnenolone 16alpha-carbonitrile | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Pregnenolone Carbonitrile results in decreased expression of ZFP395 mRNA | CTD | PMID:28903501 | propanal | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | propionaldehyde results in decreased expression of ZNF395 mRNA | CTD | PMID:26079696 | propiconazole | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | propiconazole results in decreased expression of ZFP395 mRNA | CTD | PMID:21278054 | quercetin | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of ZNF395 mRNA | CTD | PMID:21632981 | raloxifene | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [Raloxifene Hydrochloride co-treated with ESR1 protein] results in increased expression of ZNF395 mRNA and [Raloxifene Hydrochloride co-treated with ESR2 protein] results in decreased expression of ZNF395 mRNA | CTD | PMID:19059307 | resveratrol | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of ZNF395 mRNA | CTD | PMID:23557933 | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [S-(1 more ... | CTD | PMID:35811015 | SB 431542 | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF395 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of ZNF395 mRNA | CTD | PMID:25895662 | tamoxifen | multiple interactions | ISO | ZNF395 (Homo sapiens) | 6480464 | [Tamoxifen co-treated with ESR1 protein] results in increased expression of ZNF395 mRNA and [Tamoxifen co-treated with ESR2 protein] results in decreased expression of ZNF395 mRNA | CTD | PMID:19059307 | tert-butyl hydroperoxide | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of ZNF395 mRNA | CTD | PMID:15336504 | testosterone | increases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Testosterone results in increased expression of ZNF395 mRNA | CTD | PMID:33359661 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of ZFP395 mRNA | CTD | PMID:31150632 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ZFP395 mRNA] | CTD | PMID:31150632 | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of ZFP395 mRNA | CTD | PMID:34492290 | trichostatin A | increases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of ZNF395 mRNA | CTD | PMID:24935251 | troglitazone | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | troglitazone results in decreased expression of ZNF395 mRNA | CTD | PMID:28973697 | tungsten | decreases expression | ISO | Zfp395 (Mus musculus) | 6480464 | Tungsten results in decreased expression of ZFP395 mRNA | CTD | PMID:30912803 | urethane | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Urethane results in decreased expression of ZNF395 mRNA | CTD | PMID:28818685 | valproic acid | decreases methylation | ISO | ZNF395 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of ZNF395 gene | CTD | PMID:29154799 | valproic acid | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of ZNF395 mRNA | CTD | PMID:23179753 | valproic acid | affects expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ZNF395 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ZNF395 mRNA | CTD | PMID:23527032 and PMID:24935251 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of ZFP395 mRNA | CTD | PMID:23034163 | vincristine | decreases expression | ISO | ZNF395 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of ZNF395 mRNA | CTD | PMID:23649840 | |